Active Ingredient(s): Retapamulin
FDA Approved: * April 12, 2007
Pharm Company: * GLAXO GRP LTD
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Altabax Overview

Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo. Retapamulin was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. In May 2007, retapamulin received approval in the EU from the European Medicines Agency for the same indi...

Read more Altabax Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Altabax Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Ointment: 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Altabax: (4 results)

Sorted by National Drug Code
  • 0007-5180 Altabax 10 mg/g Topical Ointment by Glaxosmithkline LLC
  • 16110-518 Altabax 10 mg Topical Ointment by Aqua Pharmaceuticals
  • 21695-644 Altabax 10 mg/g Topical Ointment by Rebel Distributors Corp.
  • 54868-6096 Altabax 10 mg/g Topical Ointment by Physicians Total Care, Inc.

Other drugs which contain Retapamulin or a similar ingredient: (1 result)